97 related articles for article (PubMed ID: 3832781)
1. Methods for the evaluation of solid state stability and compatibility between drug and excipient.
Ahlneck C; Lundgren P
Acta Pharm Suec; 1985; 22(6):305-14. PubMed ID: 3832781
[No Abstract] [Full Text] [Related]
2. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
Chadha R; Bhandari S
J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
[TBL] [Abstract][Full Text] [Related]
3. Design and utilization of the drug-excipient chemical compatibility automated system.
Thomas VH; Naath M
Int J Pharm; 2008 Jul; 359(1-2):150-7. PubMed ID: 18486368
[TBL] [Abstract][Full Text] [Related]
4. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
Wu Y; Dali M; Gupta A; Raghavan K
Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
[TBL] [Abstract][Full Text] [Related]
5. Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state.
Ahlneck C; Waltersson JO
Acta Pharm Suec; 1986; 23(3):139-50. PubMed ID: 3766159
[No Abstract] [Full Text] [Related]
6. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
Thumma S; Repka MA
Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
[TBL] [Abstract][Full Text] [Related]
7. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.
Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M
J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115
[TBL] [Abstract][Full Text] [Related]
8. Solid-state compatibility studies using a high-throughput and automated forced degradation system.
Wakasawa T; Sano K; Hirakura Y; Toyo'oka T; Kitamura S
Int J Pharm; 2008 May; 355(1-2):164-73. PubMed ID: 18215480
[TBL] [Abstract][Full Text] [Related]
9. Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study.
Pires FQ; Angelo T; Silva JK; Sá-Barreto LC; Lima EM; Gelfuso GM; Gratieri T; Cunha-Filho MS
J Pharm Biomed Anal; 2017 Apr; 137():196-203. PubMed ID: 28131059
[TBL] [Abstract][Full Text] [Related]
10. A new approach to accelerated drug-excipient compatibility testing.
Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
[TBL] [Abstract][Full Text] [Related]
11. PharmDE: A new expert system for drug-excipient compatibility evaluation.
Wang N; Sun H; Dong J; Ouyang D
Int J Pharm; 2021 Sep; 607():120962. PubMed ID: 34339812
[TBL] [Abstract][Full Text] [Related]
12. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
Fathy M; Hassan MA; Mohamed FA
Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
[TBL] [Abstract][Full Text] [Related]
13. Stability challenges in drug discovery.
Di L; Kerns EH
Chem Biodivers; 2009 Nov; 6(11):1875-86. PubMed ID: 19937822
[TBL] [Abstract][Full Text] [Related]
14. Application of HPLC to assess the compatibility of bisoprolol fumarate with selected excipients in mixtures by isothermal stress testing.
Marothu VK; Yerramothu P; Gorrepati M; Majeti S; Mamidala SK; Nellutla A
Ann Pharm Fr; 2015 Nov; 73(6):442-51. PubMed ID: 26142745
[TBL] [Abstract][Full Text] [Related]
15. Compatibility of sennoside A and B with pharmaceutical excipients.
Verloop Q; Marais AF; de Villiers MM; Liebenberg W
Pharmazie; 2004 Sep; 59(9):728-30. PubMed ID: 15497761
[TBL] [Abstract][Full Text] [Related]
16. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.
Late SG; Banga AK
Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical excipient development: the need for preclinical guidance.
Baldrick P
Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
[TBL] [Abstract][Full Text] [Related]
18. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
Vandecruys R; Peeters J; Verreck G; Brewster ME
Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
[TBL] [Abstract][Full Text] [Related]
19. Calcium sulphate dihydrate: an useful excipient for tablets containing labile actives.
Eyjolfsson R
Pharmazie; 2004 Sep; 59(9):725-6. PubMed ID: 15497759
[TBL] [Abstract][Full Text] [Related]
20. [Testings of compatibility between diverse active compounds and excipients for tablets (author's transl)].
Jacob M; Lai AM; Duru C; Puech A; Mias F
J Pharm Belg; 1979; 34(2):96-8. PubMed ID: 512824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
